Literature DB >> 21836630

Optimizing evaluation of Lissamine Green parameters for ocular surface staining.

P Hamrah1, F Alipour, S Jiang, J-H Sohn, G N Foulks.   

Abstract

PURPOSE: The recently published seminal dry eye workshop proceedings defined Lissamine Green (LG), an organic dye, as a gold standard for demonstrating ocular surface staining. The purpose of the current study was to determine the optimal parameters of 1% LG instillation for the ocular surface examination in dry eye patients.
DESIGN: Prospective and observational quality improvement study.
METHODS: A quality improvement study evaluated 16 eyes from eight dry eye patients with different levels of severity. LG (1%), in three volumes (5, 10, and 20 μl) was instilled into the conjunctival cul-de-sac, and four masked observers with different levels of clinical expertise examined the patients with and without red filter. The staining pattern of the conjunctiva and cornea was documented with the Oxford scale within 4 min of LG instillation. Optimal volume and inter-observer reliability were assessed.
RESULTS: All dye volumes were tolerated well by all patients. Experienced observers preferred 10 μl volume because of the ease of examination and accuracy. Although instillation of 20 μl yielded similar scores as 10 μl, it resulted in overflow of the lid and facial skin staining. The use of red filter significantly improved reading scores (P<0.01). Inter-observer reliability was higher for conjunctival scores than for corneal scores for all patients. The highest reliability was demonstrated with 10 μl volume and increased with greater experience of the observer.
CONCLUSIONS: Ocular surface examination with instillation of 10 μl 1% LG has good inter-observer reliability and is well tolerated. Observation through a red filter facilitates the examination.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21836630      PMCID: PMC3213648          DOI: 10.1038/eye.2011.184

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  19 in total

Review 1.  The use of vital dyes in corneal disease.

Authors:  J Kim
Journal:  Curr Opin Ophthalmol       Date:  2000-08       Impact factor: 3.761

Review 2.  Grading of corneal and conjunctival staining in the context of other dry eye tests.

Authors:  Anthony J Bron; Victoria E Evans; Janine A Smith
Journal:  Cornea       Date:  2003-10       Impact factor: 2.651

Review 3.  Management and therapy of dry eye disease: report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop (2007).

Authors: 
Journal:  Ocul Surf       Date:  2007-04       Impact factor: 5.033

4.  In vitro study for staining and toxicity of rose bengal on cultured bovine corneal endothelial cells.

Authors:  Y C Lee; C K Park; M S Kim; J H Kim
Journal:  Cornea       Date:  1996-07       Impact factor: 2.651

5.  Patient tolerance and ocular surface staining characteristics of lissamine green versus rose bengal.

Authors:  F J Manning; S R Wehrly; G N Foulks
Journal:  Ophthalmology       Date:  1995-12       Impact factor: 12.079

6.  The repeatability of clinical measurements of dry eye.

Authors:  Kelly K Nichols; G Lynn Mitchell; Karla Zadnik
Journal:  Cornea       Date:  2004-04       Impact factor: 2.651

7.  Challenges and pitfalls in clinical trials of treatments for dry eye.

Authors:  Gary N Foulks
Journal:  Ocul Surf       Date:  2003-01       Impact factor: 5.033

Review 8.  Therapeutic targets in dry eye syndrome.

Authors:  Assumpta Peral; Carmen O Domínguez-Godínez; Gonzalo Carracedo; Jesús Pintor
Journal:  Drug News Perspect       Date:  2008-04

9.  Photoinactivation of herpes simplex virus by rose bengal and fluorescein. In vitro and in vivo studies.

Authors:  S E Brooks; V Kaza; T Nakamura; M D Trousdale
Journal:  Cornea       Date:  1994-01       Impact factor: 2.651

Review 10.  Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007).

Authors: 
Journal:  Ocul Surf       Date:  2007-04       Impact factor: 5.033

View more
  7 in total

1.  An in vitro depth of injury prediction model for a histopathologic classification of EPA and GHS eye irritants.

Authors:  Stewart Lebrun; Yilu Xie; Sara Chavez; Roxanne Chan; James V Jester
Journal:  Toxicol In Vitro       Date:  2019-08-13       Impact factor: 3.500

2.  Small-extracellular vesicles and their microRNA cargo from porcine follicular fluids: the potential association with oocyte quality.

Authors:  Ahmed Gad; Matej Murin; Alexandra Bartkova; Veronika Kinterova; Katerina Marcollova; Jozef Laurincik; Radek Prochazka
Journal:  J Anim Sci Biotechnol       Date:  2022-06-20

3.  Impact of Improper Approach to Identify Lid Wiper Epitheliopathy (LWE).

Authors:  Christopher W Lievens; Yvonne Norgett; Nancy Briggs; Peter M Allen; Marta Vianya-Estopa
Journal:  Clin Ophthalmol       Date:  2020-10-06

4.  Preclinical Efficacy Comparison of Cyclosporine Ophthalmic Solution 0.09% vs Cyclosporine Ophthalmic Emulsion 0.05% vs Ciclosporin Ophthalmic Emulsion 0.1% in a NOD Mouse Model of Dry Eye Disease.

Authors:  Vinod Burade; Rishit Zalawadia; Alpesh Patel; Abayomi Ogundele
Journal:  Clin Ophthalmol       Date:  2020-09-21

Review 5.  Current Approach to Dry Eye Disease.

Authors:  Valéria Valim; Virginia Fernandes Moça Trevisani; Jacqueline Martins de Sousa; Verônica Silva Vilela; Rubens Belfort
Journal:  Clin Rev Allergy Immunol       Date:  2015-12       Impact factor: 8.667

Review 6.  Diagnosis of dry eye disease and emerging technologies.

Authors:  Maya Salomon-Ben Zeev; Darby Douglas Miller; Robert Latkany
Journal:  Clin Ophthalmol       Date:  2014-03-20

7.  Presence of Histatin-1 in Human Tears and Association with Aqueous Deficient Dry Eye Diagnosis: A Preliminary Study.

Authors:  Sushma Kalmodia; Kyung-No Son; Dingcai Cao; Bao-Shiang Lee; Bayasgalan Surenkhuu; Dhara Shah; Marwan Ali; Arun Balasubramaniam; Sandeep Jain; Vinay Kumar Aakalu
Journal:  Sci Rep       Date:  2019-07-16       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.